Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-20-024558
Date:2020-04-13
Issuer: ADAPTIVE BIOTECHNOLOGIES CORP (ADPT)
Original Submission Date:

Reporting Person:

ROBINS CHAD M
C/O ADAPTIVE BIOTECHNOLOGIES CORPORATION
1551 EASTLAKE AVE E STE 200 SEATTLE, WA 98102

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2020-04-13 M 5,560 a $0.33 1,883,740 direct
COMMON STOCK 2020-04-13 S 1,500 d $24.83 1,882,240 direct
COMMON STOCK 2020-04-13 S 900 d $25.62 1,881,340 direct
COMMON STOCK 2020-04-13 S 3,160 d $26.74 1,878,180 direct
COMMON STOCK 2020-04-14 M 33,360 a $0.33 1,911,540 direct
COMMON STOCK 2020-04-14 S 33,360 d $28.20 1,878,180 direct
COMMON STOCK 2020-04-15 M 11,120 a $0.33 1,889,300 direct
COMMON STOCK 2020-04-15 S 500 a $27.62 1,888,800 direct
COMMON STOCK 2020-04-15 S 10,620 d $28.34 1,878,180 direct
COMMON STOCK 2020-04-13 0 $0.00 500,000 f8 indirect
COMMON STOCK 2020-04-13 0 $0.00 350,000 f8 indirect
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 0.33 2020-04-13 deemed execution date M 5,560 (d) 2021-12-20 common stock 5,560 $0.33 691,040 direct
STOCK OPTION (RIGHT TO BUY) 0.33 2020-04-14 deemed execution date M 33,360 (d) 2021-12-20 common stock 33,360 $0.33 657,680 direct
STOCK OPTION (RIGHT TO BUY) 0.33 2020-04-15 deemed execution date M 11,120 (d) 2021-12-20 common stock 11,120 $0.33 646,560 direct
Footnotes
IDfootnote
f1 these transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 22, 2019.
f2 the price reported for this transaction is a weighted-average price. the shares were sold in multiple transactions ranging from $24.31 to 25.26, inclusive. the reporting person undertakes to provide to adaptive biotechnologies corporation, any security holder of adaptive biotechnologies corporation, or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this form 4.
f3 the price reported for this transaction is a weighted-average price. the shares were sold in multiple transactions ranging from $25.34 to 26.11, inclusive.
f4 the price reported for this transaction is a weighted-average price. the shares were sold in multiple transactions ranging from $26.42 to 27.30, inclusive.
f5 the price reported for this transaction is a weighted-average price. the shares were sold in multiple transactions ranging from $27.78 to 28.45, inclusive.
f6 the price reported for this transaction is a weighted-average price. the shares were sold in multiple transactions ranging from $27.55 to 27.72, inclusive.
f7 the price reported for this transaction is a weighted-average price. the shares were sold in multiple transactions ranging from $27.79 to 28.73, inclusive.
f8 the reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
f9 the options are fully vested and exercisable.
WhaleWisdom Logo

Elevate your investments